Polynucleotides for use in recombinant adeno-associated...

Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S369000, C435S320100, C536S023100, C536S023720

Reexamination Certificate

active

07125705

ABSTRACT:
Accessory functions capable of supporting efficient recombinant AAV (rAAV) virion production in a suitable host cell are provided. The accessory functions are in the form of one or more vectors that are capable of being transferred between cells. Methods of producing rAAV virions are also provided. The methods can be practiced to produce commercially significant levels of rAAV particles without also generating significant levels of infectious helper virus or other contaminating by-products.

REFERENCES:
patent: 5830725 (1998-11-01), Nolan et al.
patent: 5872005 (1999-02-01), Wang et al.
patent: 6686200 (2004-02-01), Dong et al.
patent: 2005/0169892 (2005-08-01), Johnson
patent: WO 96/40240 (1996-12-01), None
patent: WO 97/09441 (1997-03-01), None
patent: WO 00/22152 (2000-04-01), None
Massie et al. Improved adenovirus vector provides herpes simplex virus ribonucleotide reductase R1 and R2 subunits very efficiently. Biotechnology (N Y). vol. 13, No. 6, pp. 602-608, Jun. 1995.
No et al. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci U S A. vol. 93, No. 8, pp. 3346-3351, Apr. 1996.
Xiao et al. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. vol. 72, No. 3, pp. 2224-2232, Mar. 1998.
Inoue et al. Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors. J Virol. vol. 72, No. 9, pp. 7024-7031, Sep. 1998.
Samulski et al. Adenovirus E1B 55-Mr polypeptide facilitates timely cytoplasmic accumulation of adeno-associated virus mRNAs. J Virol. vol. 62, No. 1, pp. 206-210, Jan. 1988.
Carter, “Adeno-Associated Virus Helper Functions,”Handbook of Paroviruses1(13):255-282 (1990).
Carter et al., “Properties of an Adenovirus Type 2 Mutant, Ad2dl807, Having a Deletion Near the Right-hand Genome Terminus: Failure to Help AAV Replication,”Virology126:505-516 (1983).
Georg-Fries et al., “Analysis of Proteins, Helper Dependence, and Seroepidemiology of a New Human Parovirus,”Virology134:64-71 (1984).
Handa, “Complementation of Adeno-Associated Virus Growth with Temperature-Sensitive Mutants of Human Adenovirus Types 12 and 5,”J. Gen. Virol. 29:239-242 (1975).
Ito, M., “Adeno-associated Satellite Virus Growth Supported by a Temperature-sensitive Mutant of Human Adenovirus,”J. Gen. Virol. 9:243-245 (1970).
Janik et al., “Locations of Adenovirus Genes Required for the Replication of Adenovirus-associated Virus,”Proc. Natl. Acad. Sci.USA78 (3):1925-1929 (1981).
Jay et al., “Eukaryotic Translational Control: Adeno-associated Virus Protein Synthesis is Affected by a Mutation in the Adenovirus DNA-binding Protein,”Proc. Natl. Acad. SCI. USA78(5):2927-2931 (1981).
Laughlin et al., “Effect of Deletions in Adenovirus Early Region 1 Genes Upon Replication of Adeno-Associated Virus,”J. Virol. 41(3):868-876 (1982).
Myers et al., “Adeno-Associated Virus Replication. The Effect ofL-Canavanine or a Helper Virus Mutation on Accumulation of Viral Capsids and Progeny Single-Stranded DNA,”J. Biol. Chem. 256(2):567-570 (1981).
Myers et al., “Adenovirus Helper Function for Growth of Adeno-Associated Virus: Effect of Temperature-Sensitive Mutations in Adenovirus Early Gene Region 2,”J. Virol. 35(1):65-75 (1980).
Ostrove et al., “Adenovirus Early Region 1b Gene Function Required for Rescue of Latent Adeno-Associated Virus,”Virology104:502-505 (1980).
Richardson et al., “A cascade of Adenovirus Early Functions is Required for Expression of Adeno-Associated Virus,”Cell27(2):133-141 (1981).
Straus et al., “DNA-Minus Temperature-Sensitive Mutants of Adenovirus Type 5 Help Adenovirus-Associated Virus Replication,”J. Virology17:140-148 (1976).
Wang et al., “A Packaging Cell Line for Propagation of Recombinant Adenovirus Vectors Containing Two Lethal Gene-Region Deletions,”Gene Therapy2:775-783 (1995).
Matsushita et al. (1998) “Adeno-associated virus vectors can be efficiently produced without helper virus,”Gene Therapy, 5(7):938-945.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Polynucleotides for use in recombinant adeno-associated... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polynucleotides for use in recombinant adeno-associated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotides for use in recombinant adeno-associated... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3659449

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.